Primary interstitial lung disease specific to childhood

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:264665
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Primary interstitial lung disease specific to childhood (chILD) is a heterogeneous group of rare respiratory disorders that predominantly affect the lung interstitium — the tissue and space around the air sacs (alveoli) — in infants and children. Unlike interstitial lung diseases seen in adults, these childhood-specific forms involve distinct entities related to abnormal lung development, surfactant metabolism dysfunction, and other processes unique to the growing lung. This group encompasses conditions such as neuroendocrine cell hyperplasia of infancy (NEHI), pulmonary interstitial glycogenosis, diffuse developmental disorders of the lung, and surfactant protein deficiencies (including mutations in SFTPB, SFTPC, ABCA3, and NKX2-1). Key symptoms include persistent tachypnea (rapid breathing), hypoxemia (low blood oxygen levels), chronic cough, failure to thrive, exercise intolerance, and respiratory distress that may present from the neonatal period through later childhood. Chest imaging typically reveals diffuse infiltrates, ground-glass opacities, or other interstitial patterns, and lung biopsy may be required for definitive diagnosis in some subtypes. The severity ranges widely — from mild disease with gradual improvement to severe, life-threatening respiratory failure. Treatment is largely supportive and depends on the specific subtype. Supplemental oxygen therapy is commonly required, and nutritional support is important for children with failure to thrive. Systemic corticosteroids and hydroxychloroquine are used in some forms, though evidence for their efficacy remains limited. In the most severe cases, particularly those involving surfactant protein B deficiency, lung transplantation may be the only definitive treatment option. Management is best coordinated through multidisciplinary teams at specialized pediatric centers. Because this is a grouping category rather than a single disease entity, the inheritance pattern, prognosis, and treatment response vary considerably depending on the underlying diagnosis.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Primary interstitial lung disease specific to childhood.

View clinical trials →

No actively recruiting trials found for Primary interstitial lung disease specific to childhood at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Primary interstitial lung disease specific to childhood community →

No specialists are currently listed for Primary interstitial lung disease specific to childhood.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Primary interstitial lung disease specific to childhood.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Primary interstitial lung disease specific to childhoodForum →

No community posts yet. Be the first to share your experience with Primary interstitial lung disease specific to childhood.

Start the conversation →

Latest news about Primary interstitial lung disease specific to childhood

No recent news articles for Primary interstitial lung disease specific to childhood.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Primary interstitial lung disease specific to childhood

What is Primary interstitial lung disease specific to childhood?

Primary interstitial lung disease specific to childhood (chILD) is a heterogeneous group of rare respiratory disorders that predominantly affect the lung interstitium — the tissue and space around the air sacs (alveoli) — in infants and children. Unlike interstitial lung diseases seen in adults, these childhood-specific forms involve distinct entities related to abnormal lung development, surfactant metabolism dysfunction, and other processes unique to the growing lung. This group encompasses conditions such as neuroendocrine cell hyperplasia of infancy (NEHI), pulmonary interstitial glycogeno